Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors.

Archiv der Pharmazie
Khaled El-AdlSanadelaslam S A El-Hddad

Abstract

A novel series of 1-benzylquinazoline-2,4(1H,3H)-dione derivatives, 6a,b to 11a-e, was designed, synthesized, and evaluated for their anticancer activity against HepG2, HCT-116, and MCF-7 cells. Compounds 11b, 11e, and 11c were found to be the most potent derivatives of all tested compounds against the HepG2, HCT-116, and MCF-7 cancer cell lines, with GI50  = 9.16 ± 0.8, 5.69 ± 0.4, 5.27 ± 0.2 µM, 9.32 ± 0.9, 6.37 ± 0.7, 5.67 ± 0.5 µM, and 9.39 ± 0.5, 6.87 ± 0.7, 5.80 ± 0.4 µM, respectively. These compounds exhibited nearly the same activity as sorafenib against HepG2 and HCT-116 cells and a higher activity against MCF-7 cells (GI50  = 9.18 ± 0.6, 5.47 ± 0.3, and 7.26 ± 0.3 µM, respectively). Also, these compounds displayed a lower activity than doxorubicin against HepG2 cells and a higher activity against HCT-116 and MCF-7 cells (GI50  = 7.94 ± 0.6, 8.07 ± 0.8, and 6.75 ± 0.4 µM, respectively). The most active antiproliferative derivatives, 6a,b, 8, 9, and 11a-e, were selected to evaluate their enzymatic inhibitory activity against VEGFR-2. Compounds 11b, 11e, and 11c potently inhibited VEGFR-2 at IC50 values of 0.12 ± 0.02, 0.12 ± 0.02, and 0.13 ± 0.02 µM, respectively, which are nearly equipotent as sorafenib IC50 value (0.1...Continue Reading

References

Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Nov 5, 2005·Nature Clinical Practice. Oncology·Giampietro GaspariniNapoleone Ferrara
Oct 4, 2006·Nature Reviews. Drug Discovery·Scott WilhelmSusan Kelley
Jul 14, 2007·Current Medicinal Chemistry·Cláudio Viegas-JuniorCarlos Alberto Manssour Fraga
May 9, 2008·The New England Journal of Medicine·Robert S Kerbel
Jan 14, 2009·Journal of Molecular Graphics & Modelling·Qing-Qing XieSheng-Yong Yang
Jun 3, 2009·Nature Reviews. Gastroenterology & Hepatology·Hans Christian SpangenbergHubert E Blum
Sep 8, 2010·European Journal of Medicinal Chemistry·Ahmed M AlafeefyNabila A Al-Jaber
Sep 28, 2010·European Journal of Medicinal Chemistry·Kyungik LeeYangmee Kim
Mar 1, 2011·Bioorganic & Medicinal Chemistry Letters·Antonio GarofaloPatrick Depreux
Jun 30, 2011·The Biochemical Journal·Sina KochLena Claesson-Welsh
Sep 20, 2011·Cell·Michael PotentePeter Carmeliet
Nov 11, 2011·International Journal of Molecular Sciences·Andreas PircherMichael Medinger
Aug 10, 2012·Current Cancer Drug Targets·Anupam Bishayee, Altaf S Darvesh
May 16, 2015·Trends in Pharmacological Sciences·Peng WuMads H Clausen
Apr 27, 2017·Scientific Reports·Valentina CappelloMauro Gemmi
Jun 18, 2017·Bioorganic & Medicinal Chemistry·Hailong ZhaoBailing Xu
Dec 22, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hallah Ahmad AlyosefDirk Enke
Dec 21, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Teresa GlombPiotr Świątek
Jan 24, 2020·Frontiers in Chemistry·Zarko GagicKatarina Nikolic

❮ Previous
Next ❯

Citations

May 8, 2021·Bioorganic & Medicinal Chemistry·Abdelfattah HassanGamal El-Din A Abuo-Rahma
Oct 2, 2021·Archiv der Pharmazie·Khaled El-AdlIbrahim H Eissa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.